-
The Promise of PROTACs for Treating RET+ Lung Cancer
Read time: 3 minutes. RET proteins are a type of receptor tyrosine kinase—an important group of signaling molecules in healthy cells. When RET proteins are turned “on” and “off” in -
Small Cell Lung Cancer: The Dial Is Starting to Move
Read time: 6 minutes. The research community is finally beginning to gain traction and make real progress in treating small cell lung cancer (SCLC). The SCLC Hot Topic Meeting -
Conversations that Count: Patient Engagement Strategies to Advance Outcomes of Patients with Lung Cancer
Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts -
Conversations that Count: Transforming Lung Cancer Care Through Insight and Innovation
Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts -
Real-World Examples of Patient Involvement in Designing Clinical Trials
Read time: 2 minutes. Here we present the final video in our three-part series about how patients and researchers can work together to develop clinical trials. In the video below -
Developing Clinical Trials that Account for the Realities of Patient Life
Read time: 2 minutes. We are pleased to continue our three-part series about how patients and researchers can work together to develop clinical trials. In this second video